Mark A. Meservey

Statistics

Publications

Citations

H-Index

Active since

1993

Affiliations

Io Therapeutics (United States)(Current)

Mark A. Meservey is an author at Io Therapeutics (United States) specializing in medical microbiology, antibacterial pharmacology, and antibiotic resistance.

Publications per year

1993–1994

Publications

In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and β-lactamase stability

Michael Cohen, E. Themis Joannides, Gregory E. Roland et al. · Diagnostic Microbiology and Infectious Disease · 1994 · 21 citations

Medicine, Pharmacology, Antimicrobial Pharmacotherapy +16

In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency

Michael D. Huband, Michael Cohen, Mark A. Meservey et al. · Antimicrobial Agents and Chemotherapy · 1993 · 11 citations

Life Sciences, Medicinal Chemistry, Microbiology +12

1–2 of 2